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Abstract  
Background: Critically ill patients may die despite invasive intervention. In this study, we 
examine trends in the application of two such treatments over a decade, namely, 
endotracheal ventilation and vasopressors and inotropes administration, as well as the 
impact of these trends on survival durations in patients who die within a month of ICU 
admission.  
Methods: We considered observational data available from the MIMIC-III open-access ICU 
database and collected within a study period between year 2002 up to 2011. If a patient had 
multiple admissions to the ICU during the 30 days before death, only the first stay was 
analyzed, leading to a final set of 6,436 unique ICU admissions during the study period. We 
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tested two hypotheses: (i) administration of invasive intervention during the ICU stay 
immediately preceding end-of-life would decrease over the study time period and (ii) time-to-
death from ICU admission would also decrease, due to the decrease in invasive intervention 
administration. To investigate the latter hypothesis, we performed a subgroups analysis by 
considering patients with lowest and highest severity. To do so, we stratified the patients 
based on their SAPS I scores, and we considered patients within the first and the third 
tertiles of the score. We then assessed differences in trends within these groups between 
years 2002-05 vs. 2008-11.  
Results: Comparing the period 2002-2005 vs. 2008-2011, we found a reduction in  
endotracheal ventilation among patients who died within 30 days of ICU admission (120.8 
vs. 68.5 hours for the lowest severity patients, p<0.001; 47.7 vs. 46.0 hours for the highest 
severity patients, p=0.004). This is explained in part by an increase in the use of non-
invasive ventilation. Comparing the period 2002-2005 vs. 2008-2011, we found a reduction 
in the use of vasopressors and inotropes among patients with the lowest severity who died 
within 30 days of ICU admission (41.8 vs. 36.2 hours, p<0.001) but not among those with the 
highest severity. Despite a reduction in the use of invasive interventions, we did not find a 
reduction in the time to death between 2002-2005 vs. 2008-2011 (7.8 days vs. 8.2 days for 
the lowest severity patients, p=0.32; 2.1 days vs. 2.0 days for the highest severity patients, 
p=0.74).  
Conclusion: We found that the reduction in the use of invasive treatments over time in 
patients with very poor prognosis did not shorten the time-to-death. These findings may be 
useful for goals of care discussions.  
 
Background  
Critically ill patients commonly receive invasive interventions including endotracheal 
ventilation and continuous intravenous such as vasopressors and inotropes. These kinds of 
treatments may be administered even to patients with very poor prognosis in an attempt to 
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sustain life. About 500,000 adults die each year in the United States during or shortly after 
ICU admission1. Most of these deaths occur after decisions are made to transition the goal 
of treatment from cure to comfort measures2,3. Healthcare proxies often make these 
decisions because the decision-making capacity of the patient is impaired4,5.  
However, invasive treatments are often supportive rather than curative. Many if not 
most of patients so identified will not survive beyond a relatively short term, and are among 
the more than 1 in 5 patients in the US who die after receiving what proved to be “non-
beneficial” care in the intensive care unit (ICU)6. Endotracheal ventilation at the end of life 
deprives patients of the ability to speak with family and friends, which may severely diminish 
the patient’s quality of life in their final moments, and may engender distress among their 
surviving family and friends. However, little is known about how rates of invasive 
interventions for end-of-life patients in the ICU have changed over time, or the impact of any 
such changes on how long these patients ultimately live.  
To explore these questions, we examined trends in the application of invasive 
interventions in the ICU at one institution over the course of ten years. We hypothesized that 
rates of invasive intervention for patients who died during or soon after an ICU stay would 
decrease because of the introduction of efforts to improve end-of-life communication and 
care in the ICU. We also hypothesized that with these invasive treatments withheld or 
discontinued, these patients would likely die sooner. Importantly, the end of invasive 
interventions for patients in this study did not indicate the end of medical and nursing care.  
After discontinuation of invasive measures, comfort and symptom control measures already 
in place were continued at the end of life.  
 
Methods  
Clinical data were extracted from the MIMIC-III open-access ICU database7. The 
database comprises of almost 60,000 hospital admissions for a total of 38,645 unique adults, 
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collected from June 2001 to October 2012 in the ICUs of the Beth Israel Deaconess Medical 
Center, Boston, Massachusetts.  
Cohort of study. Our analysis included all adult patients (18 years old or older) who 
died within 30 days of their ICU admission. We considered a study period between year 
2002 up to 2011. If the patient had multiple admissions to the ICU during the 30 days before 
death, only the first stay was analyzed, leading to a final set of 6,436 unique ICU admissions 
during the study period (see Figure 1).  
Study procedure. We explored the following hypotheses: (i) administration of 
invasive intervention during the ICU stay immediately preceding end-of-life would decrease 
over the study time period and (ii) time-to-death from ICU admission would also decrease 
due to the decrease in invasive intervention administration. We compared results for the first 
hypothesis with patients who survived hospital stays. Invasive intervention was defined by 
the following variables: vasopressors and inotropes administration, which required insertion 
of a central intravenous access (as both binary variable yes/no and duration) and 
endotracheal ventilation (as both binary variable yes/no and duration). We also examined 
utilization trends of red blood cell transfusion, renal replacement therapy, extracorporeal life 
support, and existence of a “do not resuscitate” (DNR) order. Time-to-death was computed 
from the time of ICU admission. The following variables were extracted to adjust for 
confounding: age at admission, gender (binary variable, male or female), Simplified Acute 
Physiology Score or SAPS I8, Elixhauser Comorbidity Index score9 and Do Not Resuscitate 
(DNR) status at admission. All data extraction queries were performed using PostgreSQL 
(https://www.postgresql.org). We analyzed trends for the entire cohort of patients, and for 
subgroups with highest and lowest SAPS I score, to assess if any effect would be more 
pronounced for the sickest patients.  
Subgroup Analysis. To further investigate the second hypothesis, we conducted a 
subgroup analysis to examine among the patients with lowest and highest severiy whether 
we could identify a subset of patients who actually survived longer when invasive 
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interventions were withheld. Note that ‘lowest’ severity score is a relative term, as all these 
patients ultimately died within 30 days of ICU admission, and therefore had absolute 
severities higher than the general ICU population would manifest. To this extent, we 
stratified the patients based on their SAPS I scores, and then focused on the patients within 
the first and the third tertiles. The patients in the first tertile represent the lowest severity 
score, while the patients in the third tertile represent the highest severity score. We then 
performed our analysis in these two subsets and specifically, we compared trends for these 
groups between years 2002-05 vs. 2008-11.  
Statistical Analysis. The analyses were performed using the open-access software 
R 3.4 (http://www.R-project.org/). Tests for significant differences were performed for both 
binary and continuous variables. This was assessed by Chi-square test10 for binary variables 
and by t-test test11 for continuous variables. A p-value threshold of 0.05 was used to assess 
statistical significance.  
 
Results  
Characteristics for our cohort of 6,436 patients across ten years are reported in Table 
1. Age at admission, gender and SAPS I scores were similar during the study period, 
showing overall comparable clinical conditions for the patients admitted to the ICUs during 
those ten years. The single exception was an observed increase for Elixhauser scores, 
indicating that the patient population had more co-morbidities and likely a higher level of 
prior-to-admission clinical severity (Table 1). Over the study period, we observe a 
significantly decreasing trend in the administration of invasive interventions (use of 
vasopressors and inotropes and endotracheal ventilation, see also Table 2), which was 
consistent with our first hypothesis. This trend was also seen among the ICU patients who 
survived their hospitalization (see Figures 2-3). The use of non-invasive ventilation increased 
(see Table 2) during the study interval. We also found a reduction in the administration of red 
blood cell transfusion among the ICU patients who died during the study period but observed 
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a slight but not significant up-trend in the use of renal replacement therapy in this cohort 
(data not shown). The use of extracorporeal life support was steady at <1% among those 
who died throughout the study period (data not shown).  
Despite a reduction in the use of endotracheal ventilation and vasopressors and 
inotropes over time among ICU patients who did not survive, and contrary to our second 
hypothesis, we found no change in median time-to-death from admission to the ICU (Table 
2). There was an upward trend in the number of patients with a “do not resuscitate” or DNR 
order at the time of ICU admission (see Table 2). The proportion of patients who died as a 
result of unsuccessful cardio-pulmonary resuscitation was very low throughout the study 
period at <1%, suggesting that the vast majority of patients died because of termination of 
curative treatments (data not shown).  
The results for the lowest severity score patients resembled the trends observed in 
the whole population. However, the highest severity score patients show slightly different 
results; endotracheal ventilation use followed a similar decreasing trend as the overall group, 
but the use of vasopressors and inotropes remained constant (i.e., no statistical difference) 
during the study period (75% vs 71% patients were administered vasopressors and 
inotropes in the two earliest and most recent years for a median duration of 24 and 27 hours 
respectively). Time-to-death remained unchanged in both groups. To more clearly present 
the findings within the subgroups, we show average results of these two groups of patients 
during a period of the earliest  years (2002 to 2005) and the most recent years (2008 to 
2011) (Table 2).  
 
Discussion  
While clinicians cannot predict whether a patient will die before a certain time, they 
can identify patients with particularly poor prognoses. We included such patients by 
extracting data from the ICU subpopulation that did not survive more than a month past ICU 
admission from 2002 to 2011 to derive insight into the impact of invasive interventions on 
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their eventual outcomes. Midway through this time period, an educational curriculum was 
introduced to the ICU residents that provided training in end-of-life communication skills. 
Though observational, our analyses of time trends in one large institution suggest that in 
accordance with our hypothesis, these interventions are being employed less frequently in 
this group. This trend may be partly explained by an increase in patients with DNR orders, 
which was likely the effect of an end-of-life communication course that was introduced in 
2008 to the residents rotating in the medical ICU, as well as heightened discussion around 
advanced directives in the mainstream media.  However, contrary to our hypothesis, 
reducing invasive interventions for critically ill patients did not result in a shorter time to 
death.  These results demonstrate that for patients identified to have extremely poor 
prognoses, longevity is unimpaired when invasive interventions are withheld or withdrawn. In 
fact, the quality of the remaining life available to these patients is very likely to be enhanced 
by the absence of such interventions.  
To our knowledge, this is the first investigation into trends of invasive intervention for 
end-of-life care and the impact of their utilization on time to death. However such findings 
are not without precedent. One study of palliative care patients found that such care can 
result in reduced use of invasive interventions  and higher quality of life  in terminal 
metastatic non-small cell lung cancer patients12. Other studies13 have found reduced lengths 
of stay in an ICU after a separate palliative care unit was opened. The increase in the use of 
non-invasive ventilation during the study interval may account for some (or all) of the survival 
observed in patients in whom endotracheal ventilation was discontinued14. It is less clear 
why the discontinuation of vasopressors and inotropes support should result in little survival 
change. Perhaps when endotracheal ventilation was not initiated or discontinued, the 
cardiovascular system may benefit from removal of the adverse effects of positive pressure 
ventilation on cardiovascular physiology. It is also possible that the clinicians are more likely 
to accept values outside the “norm” for blood pressure and/or oxygen saturation than they 
would for patients with better expected outcomes.  
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The trend we observed toward decreasing use of invasive intereventions at the end 
of life has been previously reported. One recent study within a French ICU found a 
substantial increase in over the course of a four-year interval in the proportion of patients 
dying in the ICU with limitations, an increase in patients discharged alive after treatment 
withholding decisions, and a reduction in failed resuscitation15. During that time mortality 
remained stable, which provides additional support for our finding that there may not be a 
stark tradeoff between invasive interventions and survival at the end of life.  
Further research is needed to corroborate these findings. If the findings hold, the use 
of invasive interventions in the ICU for poor prognosis patients who are not responding to 
ICU care should be fundamentally reconceptualized as a high-risk form of treatment, and 
decision support tools will be needed to help ICU clinicians determine which patients will 
likely benefit from invasive interventions, which are not likely to benefit, and which may 
actually be harmed by them.  
Our analysis has several important limitations. This is an observational study and 
therefore may not imply causality. In addition, it is a single center study, and there may be 
additional confounders for which we did not adjust. Still, these results raise important 
questions about current approaches to invasive intervention in patients who are likely to be 
near the end of life.  
 
Conclusions  
Despite the expectation that patients would die sooner if invasive interventions were 
withheld or discontinued, we found no such association. Although it is likely that some 
individuals died more quickly because endotracheal ventilation and/or vasopressors and 
inotropes were not administered, for other patients, such invasive interventions may hasten 
their deaths. Therefore, the assumption that invasive intervention is always life sustaining in 
this context may be incorrect. For clinicians carrying on end of life discussions with patients 
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and families regarding using, withholding or discontinuing invasive  therapies, our findings 
should provide useful information in terms of the likely impact of such decisions on remaining 
survival durations.  
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Tables  
Independent variables Dependent variables 
Year Number 
subjects 
Age Gender 
(male) 
SAPS I 
Score 
Elixhauser 
Score  
Vasopress
ors and 
inotropes 
(Yes/No) 
Endotrache
al 
Ventilation 
(Yes/No) 
Vasopress
ors and 
inotropes 
(duration in 
hours) 
Endotrach
eal 
Ventilation 
(duration in 
hours) 
Time to 
death 
(days)  
2002 458 74 
[22] 
50.87% 22 
[9] 
11 
[17] 
38.08% 74.25% 67.37 
[113.12] 
124.87 
[176.19] 
5.20 
[11.46] 
2003 490 75 
[21] 
50.00% 22 
[8] 
12 
[18] 
27.00% 83.75% 22.50 
[74.87] 
112.97 
[186.00] 
5.27 
[12.53] 
2004 468 72 
[24] 
56.83% 22 
[7] 
12 
[18] 
32.00% 85.00% 32.33 
[70.83] 
134.50 
[162.87] 
5.04 
[10.29] 
2005 595 75 
[21] 
49.24% 22 
[8] 
17 
[20] 
32.42% 79.00% 51.75 
[81.25] 
116.00 
[155.25] 
5.29 
[10.35] 
2006 555 74 
[23] 
53.69% 21 
[7] 
17 
[19] 
30.92% 81.50% 34.00 
[68.25] 
111.50 
[191.91] 
6.41 
[12.12] 
2007 659 75 
[22] 
55.38% 21 
[8] 
16 
[19] 
26.17% 59.75% 21.58 
[39.50] 
69.37 
[96.57] 
4.58 
[11.14] 
2008 644 77 
[21] 
51.08% 21 
[8] 
16 
[19] 
31.19% 56.00% 34.67 
[50.88] 
58.50 
[116.63] 
4.95 
[11.26] 
2009 666 75 
[23] 
50.60% 22 
[7] 
19 
[19] 
35.03% 64.00% 52.27 
[86.63] 
80.61 
[187.69] 
5.02 
[10.98] 
2010 634 75 
[21] 
56.94% 21.5 
[7.75] 
17 
[20] 
32.19% 62.17% 26.83 
[52.70] 
59.89 
[119.32] 
4.97 
[11.07] 
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2011 636 75 
[22] 
53.14% 22 
[7] 
18 
[20] 
33.72% 65.00% 38.27 
[49.70] 
81.71 
[120.23] 
5.54 
[12.46] 
Table 1. Characteristics for the cohort of 6,436 patients who died within 30 days from their ICU admission 
between 2002 and 2011 and trend through the 10 years for all the covariates. For gender, we show the 
percentage of male for each year. For vasopressors and inotropes (Yes/No), and for endotracheal 
ventilation (Yes/No) we provide percentage of patients who received the treatments. For all the other 
covariates we show median values with interquartile ranges.  
 
Covariate / 
Cohort 
Lower 
severity 
score 
2002-2005 
Lower 
severity 
score 
2008-2011 
P-value  Higher 
severity 
score 
2002-2005 
Higher 
severity 
score  
2008-2011 
P-value  
Vasopressors 
and inotropes 
(duration in 
hours) 
41.8 [+/- 86.2] 34.8 [+/- 82.8] p-value<0.001 24.3 [+/- 77.0] 26.6 [+/- 68.3] p-value=0.12 
Endotracheal 
Ventilation 
(duration in 
hours) 
120.8 [+/- 148.8] 68.2 [+/- 134.8] p-value<0.001 47.7 [+/- 123.0] 46.0 [+/- 120.4] p-value=0.004 
Proportion of 
Non-Invasive 
Ventilation 
Use 
3.5% 5.7% p-value=0.09 1.3% 6.6% p-value<0.001 
Proportion of 
Patients with 
Do-not-
resuscitate or 
14.5% 25.9% p-value<0.001 14.7% 20.6% p-value=0.01 
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DNR status 
Median Time 
to Death 
(days) 
7.8 [+/- 8.3]  8.2 [+/- 8.6]  p-value=0.32 2.1 [+/- 6.8] 2.0 [+/- 6.8]  p-value=0.74 
Table 2. Comparison of the characteristics of the patients within the lower and higher severity score 
groups during the earlier years (2002 to 2005) and the later ones (2008 to 2011).  
 
Figures  
 
Figure 1. Patient Cohort.  
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Figure 2. Percentage of patients and standard error who received vasopressors and intropes between 
2002 and 2011. Cohort: 6,436 patients who died within 30 days of ICU admission and 40,041 patients who 
did not die.  
 
 
Figure 3. Percentage of patients and standard error who were treated with endotracheal ventilation 
between 2002 and 2011. Cohort: 6,436 patients who died within 30 days of ICU admission and the 40,041 
patients who did not die.  
 
